11-61118282-T-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_014207.4(CD5):āc.202T>Gā(p.Ser68Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000119 in 1,614,214 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_014207.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CD5 | NM_014207.4 | c.202T>G | p.Ser68Ala | missense_variant | 3/11 | ENST00000347785.8 | NP_055022.2 | |
CD5 | NM_001346456.2 | c.31T>G | p.Ser11Ala | missense_variant | 3/11 | NP_001333385.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CD5 | ENST00000347785.8 | c.202T>G | p.Ser68Ala | missense_variant | 3/11 | 1 | NM_014207.4 | ENSP00000342681 | P1 | |
CD5 | ENST00000544014.1 | c.202T>G | p.Ser68Ala | missense_variant | 3/5 | 4 | ENSP00000440899 |
Frequencies
GnomAD3 genomes AF: 0.0000854 AC: 13AN: 152206Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000159 AC: 40AN: 251400Hom.: 0 AF XY: 0.000184 AC XY: 25AN XY: 135898
GnomAD4 exome AF: 0.000122 AC: 179AN: 1461890Hom.: 0 Cov.: 32 AF XY: 0.000127 AC XY: 92AN XY: 727248
GnomAD4 genome AF: 0.0000853 AC: 13AN: 152324Hom.: 0 Cov.: 33 AF XY: 0.0000671 AC XY: 5AN XY: 74480
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 02, 2021 | The c.202T>G (p.S68A) alteration is located in exon 3 (coding exon 3) of the CD5 gene. This alteration results from a T to G substitution at nucleotide position 202, causing the serine (S) at amino acid position 68 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at